Company profile for Maxion Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Developer of drug discovery platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines ion channel-modulating mini-proteins found in venom and other sources called knottins into the antibody surface to create mixtures by preserving the ion channel modulating the function of knottins while enjoying the optimum drug-like properties of antibodies. enabling patients...
Developer of drug discovery platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines ion channel-modulating mini-proteins found in venom and other sources called knottins into the antibody surface to create mixtures by preserving the ion channel modulating the function of knottins while enjoying the optimum drug-like properties of antibodies. enabling patients to treat diseases such as chronic pain, autoimmune disorders, and heart disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Babraham Research Campus Cambridge CB22 3AT
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/01/3159504/0/en/Maxion-Therapeutics-Appoints-Joel-Edwards-as-Chief-Business-Officer.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/08/27/3139928/0/en/Maxion-Therapeutics-Strengthens-Board-with-Appointment-of-Dr-Santiago-Arroyo-as-a-Non-Executive-Director.html

GLOBENEWSWIRE
27 Aug 2025

https://www.globenewswire.com/news-release/2025/06/17/3100584/0/en/Maxion-Therapeutics-Appoints-Dr-Stefan-H%C3%A4rtle-as-Chief-Development-Officer.html

GLOBENEWSWIRE
17 Jun 2025

https://www.globenewswire.com/news-release/2025/03/17/3043657/0/en/Maxion-Therapeutics-Raises-72-million-58-million-in-an-Oversubscribed-Series-A-Financing-to-Advance-its-KnotBody-Pipeline-and-Platform.html

GLOBENEWSWIRE
17 Mar 2025

https://www.prnewswire.com/news-releases/maxion-therapeutics-welcomes-dr-arndt-schottelius-as-new-ceo-302049474.html

PR NEWSWIRE
01 Feb 2024

https://www.prnewswire.com/news-releases/ion-channel-drug-developer-maxion-therapeutics-appoints-eva-lotta-allan-as-chair-of-its-board-of-directors-301933959.html

PR NEWSWIRE
21 Sep 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty